2024
Factors associated with non-publication of clinical trials in cardiovascular medicine: a cross-sectional analysis
Alawajneh M, Aljabai A, Theeb L, Badwan Z, Alnabi A, Theeb H, Altibi A. Factors associated with non-publication of clinical trials in cardiovascular medicine: a cross-sectional analysis. European Heart Journal 2024, 45: ehae666.3639. DOI: 10.1093/eurheartj/ehae666.3639.Peer-Reviewed Original ResearchCross-sectional analysisClinical trialsIntervention typeLogistic regressionCardiovascular medicineNon-randomised trialsOpen-label trialPublication statusMultivariate logistic regressionArea of clinical researchEnrollment sizeNon-publicationCardiovascular clinical trialsCardiovascular-relatedParticipant ageTriple-blindTrial completionDecreased likelihoodRandomised trialsTrial publicationsPredictor factorsFunding sourcesResearch fundingClinical researchEnrollment
2023
Baseline and Longitudinal Imaging of Hypertrophic Cardiomyopathy in the Era of Emerging Therapeutics
Altibi A, Alani A, Zhao Y, Masri A. Baseline and Longitudinal Imaging of Hypertrophic Cardiomyopathy in the Era of Emerging Therapeutics. Current Cardiology Reports 2023, 25: 583-595. PMID: 37103749, DOI: 10.1007/s11886-023-01883-w.Peer-Reviewed Original ResearchConceptsCardiac myosin inhibitorCardiac magnetic resonance imagingHypertrophic cardiomyopathyCare of patientsClinical trialsPathophysiology of hypertrophic cardiomyopathyCardiac magnetic resonanceNew drug therapiesHypertrophic cardiomyopathy diagnosisActin-myosin cross-bridgesLongitudinal imagingMagnetic resonance imagingMyosin inhibitorTherapeutic optionsAbstract PurposeDrug therapyOral moleculesLongitudinal imaging modalityCardiomyopathyPatientsMonitoring patientsImaging modalitiesResonance imagingInvestigate new drug therapiesSarcomere level